240 related articles for article (PubMed ID: 17355216)
1. Advances in ischemic stroke treatment: neuroprotective and combination therapies.
Lapchak PA; Araujo DM
Expert Opin Emerg Drugs; 2007 Mar; 12(1):97-112. PubMed ID: 17355216
[TBL] [Abstract][Full Text] [Related]
2. Alteplase and ischaemic stroke: have new reviews of old data helped?
Lindley RI; Wardlaw JM; Sandercock PA
Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis and neuroprotection in cerebral ischemia.
Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
[TBL] [Abstract][Full Text] [Related]
4. Progress in Intravenous Thrombolytic Therapy for Acute Stroke.
Marshall RS
JAMA Neurol; 2015 Aug; 72(8):928-34. PubMed ID: 26030910
[TBL] [Abstract][Full Text] [Related]
5. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
6. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
8. Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.
Zhu Z; Fu Y; Tian D; Sun N; Han W; Chang G; Dong Y; Xu X; Liu Q; Huang D; Shi FD
Circulation; 2015 Sep; 132(12):1104-1112. PubMed ID: 26202811
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke.
Ly JV; Zavala JA; Donnan GA
Expert Opin Pharmacother; 2006 Aug; 7(12):1571-81. PubMed ID: 16872260
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.
Zhou H; Huang S; Sunnassee G; Guo W; Chen J; Guo Y; Tan S
Int J Neurosci; 2017 Nov; 127(11):1036-1046. PubMed ID: 28110588
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Alteplase for Acute Ischemic Stroke in Taiwan: Can We Expand the National Health Insurance's Reimbursement Criteria?
Hsieh CY
Acta Neurol Taiwan; 2017 Mar; 26(1):1-2. PubMed ID: 28752507
[TBL] [Abstract][Full Text] [Related]
14. Combination of thrombolytic therapy and neuroprotective therapy in acute ischemic stroke: is it important?
Wang Y; Li Q; Wang J; Zhuang QK; Zhang YY
Eur Rev Med Pharmacol Sci; 2015; 19(3):416-22. PubMed ID: 25720713
[TBL] [Abstract][Full Text] [Related]
15. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
16. Hyperacute stroke therapy with tissue plasminogen activator.
Alberts MJ
Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
[TBL] [Abstract][Full Text] [Related]
17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
Külkens S; Hacke W
Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
Padma V; Fisher M; Moonis M
Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
[TBL] [Abstract][Full Text] [Related]
20. Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke.
Geng J; Song Y; Mu Z; Xu Q; Shi G; Sun Y; Chen Y; Lin Y; Pan Y; Yu L; Yang GY; Li Y
Acta Neurochir Suppl; 2016; 121():269-75. PubMed ID: 26463960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
